[SINGAPORE] After more than two decades of strategic investment, Singapore has cultivated a vibrant biotech startup scene, underpinned by a well-established R&D ecosystem. The city-state is now home to more than 70 such companies – a sevenfold increase since 2012, according to Dr Clarice Chen, director of healthcare and biomedical at Enterprise Singapore. However, as they scale, not many opt to raise capital by listing on the Singapore Exchange (SGX).   https://www.businesstimes.com.sg/singapore/biopharma-scene-singapore-vibrant-few-make-it-sgx (ICE SINGAPORE)

Fonte notizia: The Business Times, 28 September 2025